THE NOVO NORDISK UK RESEARCH FOUNDATION
* Promoting research into the causes and treatment of diabetes mellitus and publishing the useful result thereof.* The preservation and protection of the health of the public by educating them and conducting research into the causes and prevention of diabetes.* The advancement and promotion of education in the treatment of diabetes by members of the medical profession.
Objects
THE RELIEF OF SICKNESS GENERALLY IN THE UK AND IN PARTICULAR BUT NOT SO AS TO LIMIT THE GENERALITY OF THE FOREGOING: 1) PROMOTING RESEARCH INTO THE CAUSES AND TREATMENT OF DIABETES MELLITUS AND PUBLISHING THE USEFUL RESULTS THEREOF; 2) THE PRESERVATION AND PROTECTION OF THE HEALTH OF THE PUBLIC BY EDUCATING THEM AND CONDUCTING RESEARCH INTO THE CAUSES AND PREVENTION OF DIABETES; 3) THE ADVANCEMENT AND PROMOTION OF EDUCATION IN THE TREATMENT OF DIABETES BY MEMBERS OF THE MEDICAL PROFESSION.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves increased to £183,676, which the trustees consider sufficient to cover a year's expenditure. However, the filing notes that funding has only been secured through 2026, with no confirmation for 2027 or subsequent years, leading to a cessation of new awards from 2027 onwards.
What the accounts disclose
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
“It is the policy of the charity to maintain a sufficient cash balance to cover expenditure for a year.”
“The trustees have not secured funding for 2027 or subsequent years and therefore will not be advertising awards for 2026 to ensure the Foundation has the funds to meet its existing award commitments.” — page 10
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
Year-over-year changes
- Going concern: no going-concern doubt (FY2024) → going-concern doubt noted (FY2025).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 22
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 20
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 18
- Grant-making is its main activity
Trustees
- Dr Danijela Tatovic
- Dr Dinesh Selvarajah
- Hannah Beba
- Nicholas Raymond Cahm
- Professor Pratik Choudhary
- Professor Richard Holt
- Professor Shareen Forbes
- Professor Steve Luzio
- Sandra Mulrennan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £331k | £169k |
| 31/12/2024 | £387k | £285k |
| 31/12/2023 | £273k | £322k |
| 31/12/2022 | £272k | £327k |
| 31/12/2021 | £255k | £222k |
Common questions
Is THE NOVO NORDISK UK RESEARCH FOUNDATION financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves increased to £183,676, which the trustees consider sufficient to cover a year's expenditure. However, the filing notes that funding has only been secured through 2026, with no confirmation for 2027 or subsequent years, leading to a cessation of new awards from 2027 onwards. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| Bird Song Trust | 1 | £203k |
| THE GOLDHILL FAMILY CHARITABLE TRUST | 1 | £11k |
| THE CENTRE FOR INNOVATION IN VOLUNTARY ACTION | 1 | £6k |
| THE BATCHWORTH TRUST | 1 | £5k |
| THE TANLAW FOUNDATION | 1 | £3k |
| THE ASTOR FOUNDATION | 1 | £2k |
| THE MCBAIN FAMILY FOUNDATION | 1 | £2k |
| THE OAKDALE TRUST | 1 | £2k |
Charities like this
- DIABETES RESEARCH & WELLNESS FOUNDATION
- EUROPEAN DIABETOLOGY
- THE INSULIN DEPENDENT DIABETES TRUST
- ISLE OF WIGHT DIABETIC FUND
- MEDICAL AND LIFE SCIENCES RESEARCH FUND
- SUPPORTING CHILDREN WITH DIABETES
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE NOVO NORDISK UK RESEARCH FOUNDATION | £331k | — | 0 | unclear | — | noted |
| DIABETES RESEARCH & WELLNESS FOUNDATION | £1.3m | £60,001 - £70,000 | — | unclear | — | no doubt |
| EUROPEAN DIABETOLOGY | £769k | — | 0 | unclear | — | no doubt |
| THE INSULIN DEPENDENT DIABETES TRUST | £476k | — | 0 | unclear | — | no doubt |
| ISLE OF WIGHT DIABETIC FUND | £30k | — | 0 | above | — | no doubt |
| MEDICAL AND LIFE SCIENCES RESEARCH FUND | £65k | — | 0 | unclear | — | no doubt |